1. India, M., 2021. Home: Central TB Division. [online] Tbcindia.gov.in. Available at: https://tbcindia.gov.in/ [Accessed 25 December 2021].
2. Tavares AM, Fronteira I, Couto I, Machado D, Viveiros M, Abecasis AB, Dias S. HIV and tuberculosis co-infection among migrants in Europe: A systematic review on the prevalence, incidence and mortality. PloS one. 2017 Sep 28;12(9):e0185526 doi: https://doi.org/10.1371/journal.pone.0185526 PMid:28957400 PMCid:PMC5619775
3. Bagchi S, Ambe G, Sathiakumar N. Determinants of poor adherence to anti-tuberculosis treatment in Mumbai, India. International journal of preventive medicine. 2010;1(4):223.
4. World Health Organization. WHO operational handbook on tuberculosis: module 4: treatment: drug-resistant tuberculosis treatment. https://apps.who.int/iris/bitstream/handle/10665/332398/9789240006997-eng.pdf
5. Lange C, Abubakar I, Alffenaar JW, Bothamley G, Caminero JA, Carvalho AC, Chang KC, Codecasa L, Correia A, Crudu V, Davies P. Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement.